These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24636201)

  • 1. Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis.
    Wang X; Guo X; Yu W; Li C; Gui Y; Cai Z
    BMC Cancer; 2014 Mar; 14():196. PubMed ID: 24636201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells.
    Chen H; Xia M; Lin M; Yang H; Kuhlenkamp J; Li T; Sodir NM; Chen YH; Josef-Lenz H; Laird PW; Clarke S; Mato JM; Lu SC
    Gastroenterology; 2007 Jul; 133(1):207-18. PubMed ID: 17631143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer.
    Tomasi ML; Ryoo M; Skay A; Tomasi I; Giordano P; Mato JM; Lu SC
    Exp Cell Res; 2013 Jul; 319(12):1902-1911. PubMed ID: 23588207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.
    Strekalova E; Malin D; Weisenhorn EMM; Russell JD; Hoelper D; Jain A; Coon JJ; Lewis PW; Cryns VL
    Breast Cancer Res Treat; 2019 May; 175(1):39-50. PubMed ID: 30712196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTORC1-independent translation control in mammalian cells by methionine adenosyltransferase 2A and S-adenosylmethionine.
    Alam M; Shima H; Matsuo Y; Long NC; Matsumoto M; Ishii Y; Sato N; Sugiyama T; Nobuta R; Hashimoto S; Liu L; Kaneko MK; Kato Y; Inada T; Igarashi K
    J Biol Chem; 2022 Jul; 298(7):102084. PubMed ID: 35636512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer.
    Yang H; Huang ZZ; Zeng Z; Chen C; Selby RR; Lu SC
    Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G184-90. PubMed ID: 11208539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis.
    Vázquez-Chantada M; Fernández-Ramos D; Embade N; Martínez-Lopez N; Varela-Rey M; Woodhoo A; Luka Z; Wagner C; Anglim PP; Finnell RH; Caballería J; Laird-Offringa IA; Gorospe M; Lu SC; Mato JM; Martínez-Chantar ML
    Gastroenterology; 2010 May; 138(5):1943-53. PubMed ID: 20102719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors.
    Li C; Gui G; Zhang L; Qin A; Zhou C; Zha X
    J Med Chem; 2022 Jul; 65(14):9531-9547. PubMed ID: 35796517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia induces genomic DNA demethylation through the activation of HIF-1α and transcriptional upregulation of MAT2A in hepatoma cells.
    Liu Q; Liu L; Zhao Y; Zhang J; Wang D; Chen J; He Y; Wu J; Zhang Z; Liu Z
    Mol Cancer Ther; 2011 Jun; 10(6):1113-23. PubMed ID: 21460102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.
    Quinlan CL; Kaiser SE; Bolaños B; Nowlin D; Grantner R; Karlicek-Bryant S; Feng JL; Jenkinson S; Freeman-Cook K; Dann SG; Wang X; Wells PA; Fantin VR; Stewart AE; Grant SK
    Nat Chem Biol; 2017 Jul; 13(7):785-792. PubMed ID: 28553945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
    Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.
    Tomasi ML; Ryoo M; Ramani K; Tomasi I; Giordano P; Mato JM; Lu SC
    Oncotarget; 2015 Nov; 6(35):37706-23. PubMed ID: 26416353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-Adenosylmethionine Synthesis Is Regulated by Selective N
    Shima H; Matsumoto M; Ishigami Y; Ebina M; Muto A; Sato Y; Kumagai S; Ochiai K; Suzuki T; Igarashi K
    Cell Rep; 2017 Dec; 21(12):3354-3363. PubMed ID: 29262316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
    Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
    Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.
    Lo TF; Tsai WC; Chen ST
    PLoS One; 2013; 8(9):e75628. PubMed ID: 24098708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine.
    Martínez-Chantar ML; Latasa MU; Varela-Rey M; Lu SC; García-Trevijano ER; Mato JM; Avila MA
    J Biol Chem; 2003 May; 278(22):19885-90. PubMed ID: 12660248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the methionine-methionine adenosyl transferase 2A- S -adenosyl methionine axis for cancer therapy.
    Guo J; Yang Y; Buettner R; Rosen ST
    Curr Opin Oncol; 2022 Sep; 34(5):546-551. PubMed ID: 35788128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition.
    Fogal V; Michopoulos F; Jarnuczak AF; Hamza GM; Harlfinger S; Davey P; Hulme H; Atkinson SJ; Gabrowski P; Cheung T; Grondine M; Hoover C; Rose J; Bray C; Foster AJ; Askin S; Majumder MM; Fitzpatrick P; Miele E; Macdonald R; Keun HC; Coen M
    Arch Toxicol; 2024 Aug; 98(8):2589-2603. PubMed ID: 38755480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta.
    Ramani K; Yang H; Xia M; Ara AI; Mato JM; Lu SC
    Hepatology; 2008 Feb; 47(2):521-31. PubMed ID: 18041713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.